Skip to main navigation
InVivo Therapeutics

Invivo - Investor Relations

  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Unmet Need
  • Physicians
  • Investors & Media
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • SEC Filings
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Board Diversity Matrix
    • Investor FAQs
    • Email Alerts

Invivo - Investor Relations

  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Unmet Need
  • Physicians
  • Investors & Media
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • SEC Filings
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Board Diversity Matrix
    • Investor FAQs
    • Email Alerts

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Mar 22, 2021
Document Date
Mar 18, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Invivo Therapeutics
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.
Filer
ROBERTS RICHARD JOHN

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Invivo - Investor Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR

© 2023 Invivo Therapeutics

Invivo - Site Footer Menu

  • Privacy Policy
  • Terms of Service
  • Subscribe
  • Twitter
  • Facebook
  • LinkedIn